| Optimal primary surgical treatment for advanced epithelial ovarian cancer A Elattar, A Bryant, BA Winter‐Roach, M Hatem, R Naik Cochrane database of systematic reviews, 2011 | 580 | 2011 |
| Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly (ADP-ribose … A Mukhopadhyay, A Elattar, A Cerbinskaite, SJ Wilkinson, Y Drew, S Kyle, ... Clinical cancer research 16 (8), 2344-2351, 2010 | 320 | 2010 |
| Surgical cytoreduction for recurrent epithelial ovarian cancer T Al Rawahi, AD Lopes, RE Bristow, A Bryant, A Elattar, S Chattopadhyay, ... Cochrane Database of Systematic Reviews, 2013 | 233 | 2013 |
| Clinicopathological features of homologous recombination–deficient epithelial ovarian cancers: sensitivity to PARP inhibitors, platinum, and survival A Mukhopadhyay, ER Plummer, A Elattar, S Soohoo, B Uzir, JE Quinn, ... Cancer research 72 (22), 5675-5682, 2012 | 144 | 2012 |
| Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer A Elattar, KG Warburton, A Mukhopadhyay, RM Freer, F Shaheen, ... Gynecologic oncology 124 (1), 142-147, 2012 | 69 | 2012 |
| Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery A Bryant, S Hiu, PT Kunonga, K Gajjar, D Craig, L Vale, BA Winter-Roach, ... Cochrane Database of Systematic Reviews, 2022 | 66 | 2022 |
| The use of ovarian cancer cells from patients undergoing surgery to generate primary cultures capable of undergoing functional analysis RL O′ Donnell, A McCormick, A Mukhopadhyay, LC Woodhouse, ... PloS one 9 (3), e90604, 2014 | 64 | 2014 |
| Androgen-related expression of G-proteins in ovarian cancer LA Sheach, EM Adeney, A Kucukmetin, SJ Wilkinson, AD Fisher, A Elattar, ... British journal of cancer 101 (3), 498-503, 2009 | 57 | 2009 |
| Complete cytoreduction after five or more cycles of neo-adjuvant chemotherapy confers a survival benefit in advanced ovarian cancer A Phillips, S Sundar, K Singh, J Nevin, A Elattar, S Kehoe, J Balega European Journal of Surgical Oncology 44 (6), 760-765, 2018 | 49 | 2018 |
| Maintaining surgical care delivery during the COVID-19 pandemic: A comparative cohort study at a tertiary gynecological cancer centre E Leung, Z Pervaiz, J Lowe-Zinola, S Cree, A Kwong, N Marriott, F Cole, ... Gynecologic oncology 160 (3), 649-654, 2021 | 29 | 2021 |
| The NICE classification for ‘Ultra‐radical (extensive) surgery for advanced ovarian cancer’guidance does not meaningfully predict postoperative complications: a cohort study A Phillips, S Sundar, K Singh, R Pounds, J Nevin, S Kehoe, J Balega, ... BJOG: An International Journal of Obstetrics & Gynaecology 126 (1), 96-104, 2019 | 26 | 2019 |
| Factors influencing maternal length of stay after giving birth in a UK hospital and the impact of those factors on bed occupancy A Elattar, EM Selamat, AA Robson, AD Loughney Journal of Obstetrics and Gynaecology 28 (1), 73-76, 2008 | 25 | 2008 |
| Reporting ‘Denominator’data is essential for benchmarking and quality standards in ovarian cancer A Phillips, J Balega, J Nevin, K Singh, A Elattar, S Kehoe, S Sundar Gynecologic oncology 146 (1), 94-100, 2017 | 24 | 2017 |
| Patient-reported outcomes after extensive (ultraradical) surgery for ovarian cancer: results from a prospective longitudinal feasibility study N Marriott, A Houlton, J Nevin, J Balega, K Singh, J Yap, R Sethuram, ... International Journal of Gynecological Cancer 25 (9), 1599-1607, 2015 | 24 | 2015 |
| Serum albumin as a predictor of survival after interval debulking surgery for advanced ovarian cancer (AOC): a retrospective study D Dai, J Balega, S Sundar, S Kehoe, A Elattar, A Phillips, K Singh Journal of Investigative Surgery 35 (2), 426-431, 2022 | 19 | 2022 |
| Socioeconomic differences impact overall survival in advanced ovarian cancer (AOC) prior to achievement of standard therapy A Phillips, S Kehoe, K Singh, A Elattar, J Nevin, J Balega, R Pounds, ... Archives of Gynecology and Obstetrics 300, 1261-1270, 2019 | 13 | 2019 |
| Diaphragm disease in advanced ovarian cancer: Predictability of pre-operative imaging and safety of surgical intervention R Pounds, A Phillips, S Kehoe, J Nevin, S Sundar, A Elattar, HG Teo, ... European Journal of Obstetrics & Gynecology and Reproductive Biology 226, 47-53, 2018 | 13 | 2018 |
| The evolving role of one-step nucleic acid amplification (OSNA) for the intra-operative detection of lymph node metastases: A diagnostic accuracy meta-analysis A Tranoulis, D Georgiou, J Yap, S Attard-Montalto, J Twigg, A Elattar, ... European Journal of Surgical Oncology 47 (6), 1233-1243, 2021 | 11 | 2021 |
| Predictive value of the age-adjusted Charlston co-morbidity index on peri-operative complications, adjuvant chemotherapy usage and survival in patients undergoing debulking … A Phillips, K Singh, R Pounds, S Sundar, S Kehoe, J Nevin, A Elattar, ... Journal of Obstetrics and Gynaecology 37 (8), 1070-1075, 2017 | 9 | 2017 |
| Residual disease threshold after primary surgical treatment for advanced epithelial ovarian cancer, part 1: a systematic review and network meta-analysis A Bryant, E Johnson, M Grayling, S Hiu, A Elattar, K Gajjar, D Craig, ... American Journal of Therapeutics 30 (1), e36-e55, 2023 | 8 | 2023 |
sean kehoeUniversity of OxfordZweryfikowany adres z spc.ox.ac.uk